---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-272464"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2024-12-06T23:59:59+00:00"
generated_at: "2026-05-29T06:27:08.773872+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics stockholders approve reverse stock split proposal at ratios up to 1-for-15

## Summary
- Stockholders approved reverse stock split proposal at special meeting on December 3, 2024.
- Ratio range: 1-for-2 to 1-for-15, inclusive, with board to set final ratio in its discretion.
- Vote results: 12,723,707 for, 9,810,591 against, 415,687 abstentions.
- On December 5, 2024, entered Amendment No. 2 to Rights Agreement for technical board administration changes.

## SEC filing metadata
- accession: 0001193125-24-272464
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2024-12-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312524272464/0001193125-24-272464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312524272464/d899818d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-272464
- JSON: https://secwatch.observer/filing/0001193125-24-272464.json
- Plain text: https://secwatch.observer/filing/0001193125-24-272464.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.